Software as a Medical Device (SaMD) Market to Reach USD 29.80 Billion by 2033 at 20.6% CAGR; North America Leads with 44.8% Share - Key Players: Apple, Siemens Healthineers, Philips, Viz.ai

The global Software as a Medical Device (SaMD) market was valued at USD 6.26 billion in 2025 and is projected to reach USD 29.80 billion by 2033, growing at a CAGR of 20.6% during the forecast period from 2026 to 2033. The market is experiencing rapid growth driven by the increasing adoption of digital health technologies, rising demand for real-time clinical decision support, and the expanding role of artificial intelligence in healthcare. SaMD solutions are enabling advanced diagnostics, remote monitoring, and personalized treatment, significantly improving patient outcomes and healthcare delivery efficiency.

Market growth is strongly supported by advancements in cloud computing, machine learning algorithms, and big data analytics, which are enhancing the accuracy, scalability, and interoperability of software-based medical solutions. Healthcare providers and technology companies are increasingly investing in AI-powered diagnostic tools, digital therapeutics, and predictive analytics platforms. In addition, growing regulatory approvals and evolving frameworks from agencies such as the U.S. Food and Drug Administration are accelerating product commercialization and strengthening market access. The introduction of fast-track pathways and adaptive regulatory models for digital health solutions is further boosting innovation and adoption.

SaMD is transforming modern healthcare by enabling standalone software applications to perform critical medical functions without relying on dedicated hardware devices. These solutions are widely used across radiology, cardiology, oncology, and chronic disease management, supporting early diagnosis and data-driven clinical decisions. Integration with wearable devices, telehealth platforms, and electronic health records is further enhancing usability and patient engagement.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/software-as-a-medical-devices-market?sai-v

Key Developments

February 2026: Growing adoption of AI-driven diagnostics and clinical decision support tools significantly enhanced accuracy, automation, and real-time insights in Software as a Medical Device (SaMD) platforms.

January 2026: Increasing focus on regulatory frameworks and adaptive approval pathways enabled faster validation and deployment of continuously learning SaMD solutions across global markets.

December 2025: Rising shift toward cloud-based infrastructure improved scalability, interoperability, and seamless integration of SaMD applications across healthcare ecosystems.

November 2025: Expansion of digital therapeutics and software-based treatment solutions strengthened the role of SaMD in chronic disease management and personalized care delivery.

October 2025: Increasing adoption of remote monitoring and virtual care platforms boosted demand for SaMD, enabling continuous patient tracking outside traditional clinical settings.

September 2025: Growing use of data-driven analytics and real-world evidence enhanced clinical insights, supporting better risk assessment and treatment optimization.

August 2025: Rising investments and strategic acquisitions among healthcare technology companies accelerated innovation and expansion of software-based medical solutions.

July 2025: Increasing emphasis on cybersecurity and data privacy regulations strengthened compliance requirements and trust in SaMD platforms amid expanding digital health adoption.

Key Players

Arterys Inc. | Paragon Biosciences | Viz.ai, Inc. | VitalConnect | Apple Inc. | iSchemaView, Inc. | IDx Technologies Inc. | MaxQ AI, Ltd. | Greenfinch Technology | Siemens Healthineers AG | Koninklijke Philips N.V. | Others

Purchase Corporate License | Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=software-as-a-medical-devices-market?sai-v

Rapid adoption of digital health technologies and increasing reliance on software-driven diagnostics and treatment solutions are significantly driving the growth of Software as a Medical Device (SaMD).

Rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and neurological conditions is accelerating demand for continuous monitoring and AI-enabled disease management solutions.

Growing integration of artificial intelligence and machine learning is enhancing clinical decision support, early diagnosis, and predictive analytics capabilities.

Increasing demand for remote patient monitoring and telehealth solutions is boosting adoption of SaMD platforms across healthcare ecosystems.

Favorable regulatory frameworks and increasing FDA approvals for AI-powered SaMD solutions are encouraging innovation and commercialization.

Rising need for cost-effective healthcare delivery and improved patient outcomes is driving healthcare providers toward software-based medical solutions.

Expansion of cloud computing and mobile health technologies is enabling scalable, accessible, and real-time healthcare solutions.

Growing emphasis on personalized medicine and patient-centric care is further accelerating SaMD adoption globally.

Industry Developments

Significant increase in FDA approvals of AI-driven SaMD solutions, particularly in radiology, cardiology, and pathology applications.

Rapid development of AI-first SaMD platforms enabling autonomous diagnostics and real-time clinical decision support.

Expansion of digital therapeutics and software-based treatment solutions for chronic disease management.

Growing integration of SaMD with electronic health records (EHRs) and hospital information systems to enhance interoperability and workflow efficiency.

Rising adoption of cloud-based SaMD platforms enabling remote deployment, updates, and scalability.

Increasing partnerships between technology companies, healthcare providers, and pharmaceutical firms to accelerate product development.

Continuous innovation in cybersecurity, data privacy, and regulatory compliance frameworks for SaMD solutions.

Regional Insights

North America 44.8% share: "Leads the market due to strong FDA regulatory framework, high adoption of digital health technologies, and presence of major health-tech companies."

Europe 27.0% share: "Growth supported by stringent regulatory standards, increasing digital health adoption, and rising investment in AI-based healthcare solutions."

Asia Pacific 22.5% share: "Fastest-growing region driven by expanding healthcare infrastructure, rising digital transformation, and increasing adoption in countries like China, Japan, and India."

Latin America 3.2% share: "Emerging growth supported by improving healthcare IT infrastructure and increasing awareness of digital health solutions."

Middle East & Africa 2.5% share: "Steady growth driven by rising healthcare investments and gradual adoption of advanced medical software technologies."

Speak to our analyst and get customization in the report as per your requirements: https://www.datamintelligence.com/customize/software-as-a-medical-devices-market?sai-v

Key Segments

➥ By Device Type
Wearable Device: Represents a rapidly growing segment, driven by increasing adoption of fitness trackers and smart health devices for continuous monitoring and real-time health insights.

PCs/Laptop: Represent a significant segment, supported by their use in clinical settings for data analysis, diagnostics, and comprehensive patient management.

Smartphone/Tablets: Represent the dominant segment, fueled by widespread usage, mobile health applications, and ease of access to healthcare services and monitoring tools.

➥ By Application
Diagnostic: Represents a significant segment, driven by rising demand for early disease detection, real-time data analysis, and integration of AI-powered diagnostic tools.

Clinical Management: Represents the dominant segment, supported by increasing need for continuous patient monitoring, treatment planning, and chronic disease management.

➥ By Deployment Method
Cloud-based: Represents the dominant segment, driven by scalability, remote accessibility, cost efficiency, and growing adoption of digital health ecosystems.

On-Premise: Represents a significant segment, supported by organizations requiring enhanced data security, control, and regulatory compliance.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact:
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.